US 7892539
Modulation of an innate immune response by altering TRIAL-R signaling
granted A61KA61K38/00
Quick answer
US patent 7892539 (Modulation of an innate immune response by altering TRIAL-R signaling) held by The Regents of the University of California expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00